Pilot Project Proposal: TPA Field Study The next item on the agenda was to hear a pilot project proposal for TPA activase ; field study. The project was proposed and explained by Dr. Raghaven Chari. A pilot project to use eminase in instances of cardiac problems was approved several years ago. However, when Kershaw County's new emergency services director was hired, she found that the eminase, which requires constant cold storage, had not been properly stored, thereby affecting the efficacy of the drug. She destroyed the old eminase and Dr. Chari now seeks to revive the pilot project using TPA which does not require specialized storage. Dr. DesChamps asked if all other procedures for the use of TPA remain the same as they were with eminase. Dr. Chari stated that the only difference is that TPA initial dosage is changed. Dr. Norcross asked again if the only change in the pilot project was the drug and its appropriate dosage. Dr. DesChamps asked if the project required on-line medical control. Dr. Chari's response to both questions was "yes." Dr. Baker asked if Dr. Chari was using it for a specific transport time. Dr. Chari responded "yes, unless perhaps the transport time is 10 minutes or less away." Dr. Baker made a motion to approve the pilot project with a change to TPA. The motion was seconded by Dr. Malanuk. Dr. Norcross added, "assuming there are no other changes." Dr. Malanuk then asked the length of the project. Dr. Chari responded that it will be a year-long project. The motion was approved. Dr. DesChamps affirmed that time evaluations will be included in the EMS quarterly report on the project. Proposed Changes in the Ambulance Run Report At this time, since Mr. Smith was unavailable for discussions on the drug dosage item on the agenda, the Committee then addressed the agenda item related to proposed changes in the ambulance run report. Mr. Fanning introduced the proposed changes. He said that staff would be reviewing the changes over the next few days. He asked the Committee to also consider whether a box indicator should be added to indicate where the run report is left, whether in the ICU or ER. The Committee should also consider the field triage and assessment information section. Is there anything else that should be added? This was a general suggestion by a physician to staff. Dr. Sorrell commented that in advanced procedures reconstruction of a call is difficult unless times are included for each procedure. He stated that IV information has the option for including times, but everything else should also, especially intubations and re-intubations. Dr. Miller commented that at Greenville, their nursing flow sheet is being revised to include a box chart to indicate the victim's position in the car, and or where the car hit the tree. Dr. Norcross said that an appropriate addition would be the ACS triage decision scheme. He. Rosen FS, Charache P, Pensky J et el: Hereditary angioneurotic edema: two genetic variants. Science 148: 957-958. 1965. Robson KB, Lachman RJ. Ho bart MJ et al: Linkage studies in hereditary angioedema. Genet 16: 347-350, 1979. Whorton JG: Hereditary angioedema: response to danazol. Practitioner 226: 935-936. 1982. Jaffe CJ, Atkinson JP. Gelfand JA et al: Hereditary angioedema. The use of fresh frozen plasma for prophylaxis in patients undergoing oral surgery. J Allergy Clin Immunol 55: 386-393. 1975. Frank MM, Sergenl JS. Kane MA et al: Epsilon aminocaproic acid t h e hereditary angioneurotic edema: a double blind s t u Eng J Med 286: 808-812. 1 Sheffer AL, Austen KF and Rosen FS: Tranexamic acid therapy in hereditary angioneurotic edema. N l i Med 287: 452-454. 1972. Pence HL, Evans R, Guernsey LH et al: Prophylactic use of epsilon ami nocaproic acid for oral surgery in a patient with hereditary angioneurotic edema. J Allergy Clin Immunol 53: 298-302, 1974. Spaulding WB: Methyltestosterone therapy for hereditary episodic edema hereditary angioneurotic edema ; . Ann Intern Med 739-745, 1960. Sheffer AL, Fearon DT and Austen KF: Methyltestosterone therapy in hereditary angioedema. Ann Intern Med 86: 306-308, 1977. Davis PJ, Davis FB and Charache P; Longterm therapy of hereditary angioedema HAE ; : preventive mangement with fluoxymesterone and oxymetholone in severely affected males and females. Johns Hopkins Med J 135: 391-398, 1974. Gelfand JA, Sherins RJ, Aling DW et al: Treatment of hereditary angioedema with danazol: reversal of clinical and biochemical abnormalities. New Eng J Med 295: 14441448, 1976. Potts GO: Pharmacology of danazol. J Int Med Res 5: 1-14, 1977. Smith CS and Harris F: Preliminary experience with danazol in children with precocious puberty. J Int Med Res 5: 109-110, 1977. Rescreen child referred based on acoustic immittance results within 6-8 weeks from the time of the initial test. Communicate promptly with parents guardians about the results. Request information regarding the outcome of follow-up audiological evaluations or medical examinations. The main aims of the meeting will be to promote discussion on the values attached to the safety of blood transfusion in the context of other health priorities. A, for example, danazol itp.

In addition, a nurse in an administrator role meets the standard by: advocating for systems that support safe medication administration practices; and addressing system issues that contribute to medication errors. Assistance varies with different disorders and medications. Varies by program and darvon.

It can be influenced by heart rate and stroke volume. Of these two factors, stroke volume is most significant in adults because it provides the ``surge'' that creates the systolic pressure. Except for small children and infants, the heart rate acts merely as a ``compensator'' for changes in stroke volume. For example, slow rates are common in well-trained athletes, but rapid rates are required to sustain adequate cardiac output for patients having low stroke volumes due to heart failure. Stroke volume is influenced directly by myocardial contractility, which is augmented by sympathetic stimulation of beta-1 receptors, and by venous return to the heart preload ; . According to the Frank-Starling law, preload is directly related to stroke volume, but there is a limit to this relationship. If a critical preload volume is exceeded, congestion occurs. This volume is lower for patients having compromised cardiac function, and should be considered when positioning a patient. Although the Trendelenburg position is cited most often as the preferred position for patients experiencing medical emergencies, it may allow excessive venous return increase preload ; and compromise patients with cardiac or respiratory disease. In fact, it appears this position offers few advantages.8, 9 A semi-reclined, ie, semi-Fowler, position is more appropriate when managing most medical complications. At the completion of systole, the ventricles enter a period of rest diastole ; and their pressure decreases to zero. However, blood aortic ; pressure does not decline this far because resistance within the arterial system sustains a diastolic pressure. The factor most responsible for diastolic pressure is variably called aortic resistance, systemic vascular resistance, or peripheral resistance. Although blood volume and viscosity are contributory, arterial diameter is the principal determinant of this resistance. Therefore, drugs that constrict arteries will increase diastolic pressure, and those that produce arterial dilation will decrease diastolic pressure. For the heart to eject a stroke volume, ventricular systole must generate a pressure that exceeds peripheral resistance. In other words, ventricular pressure must exceed diastolic pressure. This resistance to ventricular ejection is described as ``afterload'' and, for a patient with heart disease, elevated diastolic pressure may hinder ejection of an adequate stroke volume. For this reason, administration of vasopressors to elevate diastolic pressure could result in a negative influence on cardiac function, particularly in patients with congestive heart failure. On the other hand, coronary artery blood flow occurs during diastole, so a reasonable aortic diastolic blood pressure must be present for the heart to nourish itself before the next systolic contraction occurs. In general, a systolic pressure of 90 mm should sustain mean arterial pressure sufficiently to perfuse tis.

As none of the variables e.g. dose of allergen, dosing interval ; associated with allergen-specific immunotherapy have been studied in controlled experiments, it is impossible to make definitive recommendations. There are no data proving that one protocol is better than another. Unlike in most conventional drug therapies, the pharmacokinetic characteristics of allergenspecific immunotherapy have not been rigorously studied. By convention or habit, most protocols follow these guidelines: There can be 10 to allergens per vaccine. The initial loading phase starts with a low dose of allergen 200 to 2, 000 PNU ml ; given subcutaneously every two to seven days with incremental increases in allergen dose. A maintenance dose of 10, 000 to 20, 000 PNU ml is given every one to three weeks. Some dogs start to improve within a few weeks, but most take many months. Allergen-specific immunotherapy should be continued for at least one year before the full effects may be appreciated or a lack of response is assessed. If the immunotherapy is efficacious, continue it for the life of the dog. If it fails to improve clinical signs after one year, reevaluate the patient see below.

Abstract 1471 VARIATION IN PATIENT UTILITIES IN CHRONIC PAIN TRIALS. WHAT IS THE EFFECT ON COST-EFFECTIVENESS ANALYSIS? Marille E. Goossens, Maureen Rutten, Johan Vlaeyen, Institute for Rehabilitation Research, Hoensbroek, The Netherlands The purpose of this study is to compare the psychometric qualities of two instruments for assessing patients utilities, the rating scale RS ; and the standard gamble SG ; . Such instruments are designed for their application in economic evaluation research, but have seldomly been used in chronic pain trials. The relationship between these utility measures and descriptive and domain-specific quality of life measures was examined in 133 fibromyalgia patients and 148 patients with chronic non-specific low back pain. RESULTS: Mean utility score at baseline was .43 with the RS and .78 for the SG. The correlation between both methods was found to be poor r 0.21 ; . Both measures appeared to be fairly stable in a two-week testretest period ICC .74 and .77 ; . Scores on the description of patients own health on 6 domains, global assessment of change and domain specific measures correlated moderately with the RS scores and low with the SG. Multiple regression analyses demonstrated that 32% of the variance in RS values and only 13% of the variance in SG utilities could be explained by domain-specific measures. The results suggest acceptable construct validity for the RS but insufficient construct validity for the SG. Valuations of own health appear only partially to be related to the assessment of the pain-specific measures and measures of distress. It can be concluded that the RS and domain-specific measures assess partly different, but nevertheless complementary aspects of health-related quality of life. It is therefore recommended to include in economic evaluation studies both domainspecific measures and valuation measures. Finally, in chronic musculoskeletal pain patients, RS scores were found to be more responsive in detecting significant changes in preferences than SG scores. For use in patients with chronic musculoskeletal pain, the RS is preferred to the SG for establishing accurate decisions about the impact of new interventions on their health outcomes and levitra. Assessment 1. High risk for fluid volume deficit related to capillary damage and evaporation. Dr urmila thatte, sten olsson, and mary couper watch dr m e yeolekar, dean, lokmanya tilak municipal medical college light the lamp to inaugurate the mumbai meeting and lisinopril!